Trials / Completed
CompletedNCT00647361
Mechanical Ventilation Controlled by the Electrical Activity of the Patient's Diaphragm - Effects on Cardiac Performance
Short Term Effects of Neurally Adjusted Ventilatory Assist and Pressure Support Ventilation on Cardiac Performance
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Insel Gruppe AG, University Hospital Bern · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Neurally adjusted ventilatory assist (NAVA) is a new concept of mechanical ventilation. NAVA delivers assist to spontaneous breathing based on the detection of the electrical activity of the diaphragm. We study the effect of NAVA on cardiac performance in critically ill, mechanically ventilated patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Neurally adjusted ventilatory assist (NAVA) provided by a commercially available mechanical ventilator (Servo i, Maquet Critical Care, Solna, Sweden). | Neurally adjusted ventilatory assist (NAVA) and pressure support ventilation (PSV) |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2008-03-31
- Last updated
- 2011-07-19
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00647361. Inclusion in this directory is not an endorsement.